• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒感染会促进血液系统恶性肿瘤移植患者严重肺炎的发展。

Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies.

作者信息

Yue Caifeng, Kang ZhiJie, Ai Kexin, Xu Duorong, Wu Jim, Pan Yujia, Yan JinSong, Liu Min, Liu Quentin

机构信息

Department of Hematology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

Oncotarget. 2016 Aug 16;7(33):53930-53940. doi: 10.18632/oncotarget.10182.

DOI:10.18632/oncotarget.10182
PMID:27340772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5288233/
Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective therapy for patients with hematologic malignancies. Severe pneumonia is associated with high mortality rate in HSCT recipients. Viral co-infection indicates a poor prognosis of HSCT recipients. In this study, a total of 68 allogeneic HSCT recipients were included. Cytomegalovirus (CMV) and Respiratory syncytial virus (RSV) infection was assessed by testing peripheral blood and oropharynx swabs, respectively, collected in the first 180 days after transplantation. We analysed the correlation of CMV and RSV co-infection with severe pneumonia and mortality. The incidence of CMV and RSV co-infection was 26.5% (18/68). Severe pneumonia was diagnosed in 61% (11/18) cases with co-infection compared to only 10% (5/50) cases with mono-infection or no infection. The analysis of potential risk factors for severe pneumonia showed that CMV and RSV co-infection was significantly associated with severe pneumonia (p < 0.001). The 5 patients who died of severe pneumonia were all co-infected with CMV and RSV. In conclusion, CMV and RSV co-infection appears to be an important factor and facilitates the development of severe pneumonia in allogeneic HSCT patients with hematologic malignancies.

摘要

异基因造血干细胞移植(HSCT)是治疗血液系统恶性肿瘤患者的有效方法。严重肺炎在HSCT受者中与高死亡率相关。病毒合并感染提示HSCT受者预后不良。本研究共纳入68例异基因HSCT受者。分别通过检测移植后180天内采集的外周血和口咽拭子来评估巨细胞病毒(CMV)和呼吸道合胞病毒(RSV)感染情况。我们分析了CMV和RSV合并感染与严重肺炎及死亡率的相关性。CMV和RSV合并感染的发生率为26.5%(18/68)。合并感染的病例中有61%(11/18)被诊断为严重肺炎,而单一感染或未感染的病例中只有10%(5/50)被诊断为严重肺炎。对严重肺炎潜在危险因素的分析表明,CMV和RSV合并感染与严重肺炎显著相关(p<0.001)。5例死于严重肺炎的患者均为CMV和RSV合并感染。总之,CMV和RSV合并感染似乎是异基因HSCT血液系统恶性肿瘤患者发生严重肺炎的一个重要因素,并促进了严重肺炎的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cce/5288233/debd694fda5a/oncotarget-07-53930-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cce/5288233/63da361336ae/oncotarget-07-53930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cce/5288233/debd694fda5a/oncotarget-07-53930-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cce/5288233/63da361336ae/oncotarget-07-53930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cce/5288233/debd694fda5a/oncotarget-07-53930-g002.jpg

相似文献

1
Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies.病毒感染会促进血液系统恶性肿瘤移植患者严重肺炎的发展。
Oncotarget. 2016 Aug 16;7(33):53930-53940. doi: 10.18632/oncotarget.10182.
2
Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.对异基因造血干细胞移植受者植入前发生的呼吸道合胞病毒感染进行成功的全身大剂量利巴韦林治疗。
Transpl Infect Dis. 2013 Aug;15(4):435-40. doi: 10.1111/tid.12092. Epub 2013 May 20.
3
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.血液系统恶性肿瘤成人患者和人类干细胞移植受者的呼吸道病毒感染:在一家大型癌症中心的回顾性研究
Medicine (Baltimore). 2006 Sep;85(5):278-287. doi: 10.1097/01.md.0000232560.22098.4e.
4
Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study.血液系统恶性肿瘤患者的致命性巨细胞病毒肺炎:一项基于尸检的病例对照研究。
Clin Microbiol Infect. 2008 Dec;14(12):1160-6. doi: 10.1111/j.1469-0691.2008.02106.x. Epub 2008 Nov 25.
5
Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.血液系统恶性肿瘤成人患者呼吸道合胞病毒下呼吸道感染后死亡的危险因素。
Transpl Infect Dis. 2018 Dec;20(6):e12994. doi: 10.1111/tid.12994. Epub 2018 Sep 21.
6
Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.采用 QuantiFERON-CMV assay 对爱尔兰医院的异基因造血干细胞移植受者进行人巨细胞病毒特异性 CD8(+) T 细胞反应的体外监测。
J Med Virol. 2010 Mar;82(3):433-40. doi: 10.1002/jmv.21727.
7
Early cytomegalovirus infections following allogeneic stem cell transplantation: a comparison between non-malignant and malignant haematological disorders.异基因干细胞移植后的早期巨细胞病毒感染:非恶性与恶性血液系统疾病的比较
Hematology. 2010 Feb;15(1):4-10. doi: 10.1179/102453310X12583347009612.
8
Respiratory viral infections during the first 28 days after transplantation in pediatric hematopoietic stem cell transplant recipients.儿童造血干细胞移植受者移植后 28 天内的呼吸道病毒感染。
Clin Transplant. 2012 Sep-Oct;26(5):736-40. doi: 10.1111/j.1399-0012.2012.01607.x. Epub 2012 Mar 4.
9
Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program.强化季节性感染控制方案后成功预防呼吸道合胞病毒医院内传播。
Bone Marrow Transplant. 2011 Jan;46(1):137-42. doi: 10.1038/bmt.2010.67. Epub 2010 Apr 12.
10
Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.异基因造血干细胞移植受者的呼吸道合胞病毒感染:一项回顾性研究的发病率、临床特征和结局。
Transplantation. 2009 Nov 27;88(10):1222-6. doi: 10.1097/TP.0b013e3181bb477e.

引用本文的文献

1
Respiratory Syncytial Virus Infections in Recipients of Bone Marrow Transplants: A Systematic Review and Meta-Analysis.骨髓移植受者的呼吸道合胞病毒感染:一项系统评价与荟萃分析
Infect Dis Rep. 2024 Mar 29;16(2):317-355. doi: 10.3390/idr16020026.
2
Viral Respiratory Infections in Hematological Patients.血液学患者的病毒性呼吸道感染
Infect Dis Ther. 2020 Sep;9(3):495-510. doi: 10.1007/s40121-020-00313-6. Epub 2020 Jul 7.
3
Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy.

本文引用的文献

1
Cytomegalovirus infection in transplant recipients.移植受者中的巨细胞病毒感染。
Clinics (Sao Paulo). 2015 Jul;70(7):515-23. doi: 10.6061/clinics/2015(07)09. Epub 2015 Jul 1.
2
Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients.造血干细胞移植受者的细菌感染。
Mediterr J Hematol Infect Dis. 2015 Jul 1;7(1):e2015045. doi: 10.4084/MJHID.2015.045. eCollection 2015.
3
Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study.
人类疱疹病毒(CMV、HHV-6、HHV-7 和 EBV)在接受化疗的非移植性急性白血病患者中的合并感染。
Virol J. 2020 Mar 17;17(1):37. doi: 10.1186/s12985-020-01302-4.
4
Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation.上呼吸道呼吸道病毒检测对造血干细胞移植后下呼吸道感染的预测价值。
J Infect Dis. 2020 Jan 14;221(3):379-388. doi: 10.1093/infdis/jiz470.
5
Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.造血细胞移植受者和血液系统恶性肿瘤患者中的呼吸道合胞病毒。
Haematologica. 2019 Jul;104(7):1322-1331. doi: 10.3324/haematol.2018.215152. Epub 2019 Jun 20.
6
Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.异基因造血干细胞移植受者社区获得性呼吸道病毒下呼吸道疾病:肺病毒-细菌混合感染的危险因素及死亡率
Transpl Infect Dis. 2018 Aug;20(4):e12926. doi: 10.1111/tid.12926. Epub 2018 Jun 22.
人类疱疹病毒激活与药物性皮肤不良反应患者细胞因子谱变化的前瞻性对比研究。
Allergy. 2015 May;70(5):568-75. doi: 10.1111/all.12602. Epub 2015 Mar 16.
4
Pulmonary complications in hematopoietic SCT: a prospective study.造血干细胞移植中的肺部并发症:一项前瞻性研究。
Bone Marrow Transplant. 2014 Oct;49(10):1293-9. doi: 10.1038/bmt.2014.151. Epub 2014 Jul 21.
5
Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children.出生后 IgG 抗体对巨细胞病毒 (CMV) 的动力学和中国儿童抗 CMV IgG 的血清流行率。
Virol J. 2012 Dec 10;9:304. doi: 10.1186/1743-422X-9-304.
6
Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.造血干细胞移植后人类副流感病毒感染:危险因素、管理、死亡率和随时间的变化。
Biol Blood Marrow Transplant. 2012 Oct;18(10):1580-8. doi: 10.1016/j.bbmt.2012.04.012. Epub 2012 Apr 21.
7
Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study.异基因造血干细胞移植受者肺炎:一项多中心前瞻性研究。
Clin Transplant. 2011 Nov-Dec;25(6):E629-38. doi: 10.1111/j.1399-0012.2011.01495.x. Epub 2011 Aug 21.
8
Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.造血干细胞和实体器官移植受者的呼吸道病毒感染。
Semin Respir Crit Care Med. 2011 Aug;32(4):471-93. doi: 10.1055/s-0031-1283286. Epub 2011 Aug 19.
9
Infections in immunocompromised hosts and organ transplant recipients: essentials.免疫功能低下宿主和器官移植受者的感染:要点。
Liver Transpl. 2011 Nov;17 Suppl 3:S34-7. doi: 10.1002/lt.22378.
10
Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response.呼吸道合胞病毒干扰素拮抗剂 NS1 蛋白抑制和改变人类 T 淋巴细胞反应。
PLoS Pathog. 2011 Apr;7(4):e1001336. doi: 10.1371/journal.ppat.1001336. Epub 2011 Apr 21.